Bristol-Myers, Eisai in deal to develop cancer drug candidate 2021-06-18T03:05:49-04:00June 18th, 2021| share this article! Companies to invest up to $3.1bn to develop and market experimental drug Read More share this article! Related Posts US law firm Mayer Brown to call off Hong Kong partnership May 2nd, 2024 Australia’s second-largest pension fund blacklists thermal coal investments May 2nd, 2024 India’s Vodafone Idea in talks to avail $1.8b loans over two years May 2nd, 2024 AI-SaaS company AiDash closes Series C round at $58.5m led by Lightsmith Group May 2nd, 2024
